Perceptive Advisors LLC Cellectis S.A. Transaction History

Perceptive Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$27.78 - $38.53 $8.33 Million - $11.6 Million	-300,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$27.78 - $35.19 $1.39 Million - $1.76 Million	-50,000 Reduced 14.29%	300,000 $9.45 Million
Q4 2017 Feb 14, 2018	BUY	$23.33 - $35.01 $8.17 Million - $12.3 Million	350,000	350,000 $10.2 Million

10.8M

5.9K

1.4K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.